The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis

Published:2021-08-24 Issue:5 Volume:110 Page:1318-1328
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharmacol Ther

Author:

Kamal Mohamed A.¹,Kovalenko Pavel¹,Kosloski Matthew P.¹,Srinivasan Kamal¹,Zhang Yi¹,Rajadhyaksha Manoj¹,Lai Ching‐Ha¹,Kanamaluru Vanaja²,Xu Christine²,Sun Xian¹,Simpson Eric L.³,Paller Amy S.⁴⁵,Siegfried Elaine C.⁶⁷,Shumel Brad¹,Bansal Ashish¹,Al‐Huniti Nidal¹,Davis John D.¹^ORCID

Affiliation:

1. Regeneron Pharmaceuticals, Inc. Tarrytown New York USA

2. Sanofi Bridgewater New Jersey USA

3. Oregon Health and Science University Portland Oregon USA

4. Northwestern University Feinberg School of Medicine Chicago Illinois USA

5. Ann and Robert H. Lurie Children’s Hospital Chicago Illinois USA

6. Saint Louis University St. Louis Missouri USA

7. Cardinal Glennon Children’s Hospital St. Louis Missouri USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2366

Reference28 articles.

1. The prevalence of atopic dermatitis beyond childhood: A systematic review and meta-analysis of longitudinal studies

2. Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's Health

3. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three

4. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients

5. Guidelines of care for the management of atopic dermatitis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of Biologics in Phase III and IV Clinical Trials for Atopic Dermatitis;Journal of Clinical Medicine;2024-07-09

2. Efficacy and safety of dupilumab with concomitant topical corticosteroids in Japanese pediatric patients with moderate-to-severe atopic dermatitis: A randomized, double-blind, placebo-controlled phase 3 study;Allergology International;2024-05

3. Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs;International Journal of Molecular Sciences;2023-11-25

4. Integrated Exposure–Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis;Pharmaceutical Research;2023-11

5. Consensus on the therapeutic management of atopic dermatitis ‒ Brazilian Society of Dermatology: an update on phototherapy and systemic therapy using e-Delphi technique;Anais Brasileiros de Dermatologia;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3